Truist Financial’s Kazia Therapeutics KZIA Stock Holding History

Truist Financial’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-628	Closed	-$264K	–	2766
2021 Q4	$264K	Buy	628 +48	+8%	+$23.9K	﹤0.01%	2447
2021 Q3	$329K	Hold	580	–	–	﹤0.01%	2277
2021 Q2	$287K	Buy	580 +20	+4%	+$10.5K	﹤0.01%	2396
2021 Q1	$347K	Sell	560 -145	-21%	-$75.8K	﹤0.01%	2196
2020 Q4	$304K	Sell	705 -587	-45%	-$234K	﹤0.01%	2146
2020 Q3	$436K	Buy	+1,292	New	+$364K	﹤0.01%	1792

Other funds holding KZIA

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CFN

Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

Truist Financial's KZIA Position: Q1 2022 in Review

Truist Financial sold out of Kazia Therapeutics (KZIA) in Q1 2022, closing a stake of 628 shares — an estimated $264K sold.

Truist Financial first reported a position in KZIA in Q3 2020 and held it in 6 quarters. The position peaked at $436K in Q3 2020. 11 funds tracked by Wall St. Rank hold KZIA as of Q1 2022.

Truist Financial reported no remaining Kazia Therapeutics position as of Q1 2022 after selling out during the quarter.
Truist Financial sold 628 Kazia Therapeutics shares in Q1 2022, an estimated $264K.
Truist Financial first reported a position in Kazia Therapeutics in Q3 2020 and held it in 6 quarters.
Truist Financial's Kazia Therapeutics position peaked at $436K in Q3 2020.
11 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q1 2022.

Based on Truist Financial's 13F filing for Q1 2022, filed 22 Apr 2022.